Bio-Rad Laboratories, Inc. Releases Epstein Barr Virus Kits for Use on the BioPlex 2200 System

HERCULES, CA -- (MARKET WIRE) -- April 02, 2007 -- Bio-Rad Laboratories, Inc. (AMEX: BIO) (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has launched 2 Epstein Barr Virus (EBV) kits for use on its BioPlex® 2200 system, a diagnostic platform that employs multiplexing technology to analyze for multiple disease markers from a single patient sample.